Rachel Tsunemoto Hislop
Director/Miembro de la Junta en Abilita Therapeutics, Inc. .
Cargos activos de Rachel Tsunemoto Hislop
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Two Bear Capital Operations LLC
 Two Bear Capital Operations LLC Investment ManagersFinance Two Bear Capital Operations LLC (Two Bear Capital) is venture capital firm founded in 2019 by Mike Goguen. The firm is headquartered in Whitefish, Montana. | Inversor de Capital Privado | 01/01/2020 | - |
Abilita Therapeutics, Inc.
 Abilita Therapeutics, Inc. BiotechnologyHealth Technology Abilita Therapeutics, Inc. is a biotechnology company that focuses on discovering and developing drugs that target challenging human membrane proteins with high medical impact, such as GPCRs, ion channels, and transporters. The company is based in San Diego, CA. The company's internal drug discovery pipeline is focused on treating cancer and chronic pain. Abilita Bios EMP™ platform fuels research collaborations with pharmaceutical and biotech partners. The company was founded in 2014 by Mauro Mileni, who has been the CEO since 2014. | Director/Miembro de la Junta | - | - |
Historial de carrera de Rachel Tsunemoto Hislop
Formación de Rachel Tsunemoto Hislop.
| Massachusetts Institute of Technology | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sectorial
| Finance | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Two Bear Capital Operations LLC
Two Bear Capital Operations LLC Investment ManagersFinance Two Bear Capital Operations LLC (Two Bear Capital) is venture capital firm founded in 2019 by Mike Goguen. The firm is headquartered in Whitefish, Montana. | Finance |
Abilita Therapeutics, Inc.
Abilita Therapeutics, Inc. BiotechnologyHealth Technology Abilita Therapeutics, Inc. is a biotechnology company that focuses on discovering and developing drugs that target challenging human membrane proteins with high medical impact, such as GPCRs, ion channels, and transporters. The company is based in San Diego, CA. The company's internal drug discovery pipeline is focused on treating cancer and chronic pain. Abilita Bios EMP™ platform fuels research collaborations with pharmaceutical and biotech partners. The company was founded in 2014 by Mauro Mileni, who has been the CEO since 2014. | Health Technology |
